Alternatives for neurogenic detrusor overactivity include Ditropan XL and a liquid suspension form of solifenacin called Vesicare LS. Most of these alternatives are available in generic form and may be cheaper than Myrbetriq.

Myrbetriq is a prescription medicine for adults approved by the U.S. Food and Drug Administration (FDA) to treat the overactive bladder symptoms of urgency, frequency, and leakage. Myrbetriq was shown in studies to be effective in treating OAB symptoms of urgency, frequency and leaks within the first 4 to 8 weeks.

When taken as directed, it can help relax the smooth muscle that surrounds the bladder and increase the bladder's ability to store urine. Your doctor may prescribe Myrbetriq if you: Take too many trips to the bathroom.

Excretion: The mean elimination half-life (t1/2) of mirabegron is approximately 50 hours in adult patients and 26 to 31 hours in pediatric patients(mirabegron granules). Renal elimination of mirabegron is primarily through active tubular secretion and glomerular filtration.

Average 12 Month Prices for Myrbetriq

Oxybutynin is another first-choice medication for treating OAB. Similar to Myrbetriq, it's also FDA-approved to treat OAB symptoms of urinary urgency, frequency, and leakage in adults.

It's important that you take Myrbetriq 1 time a day as prescribed by your doctor. In clinical studies, it took 4-8 weeks for some people to start seeing an improvement in OAB symptoms. Further improvements may be seen within 12 weeks for some people. Your results may vary.

It's best to take Myrbetriq at around the same time of day. This helps maintain a steady level of the drug in your body so Myrbetriq can work effectively. Choose a dosing time that works for you and try to stick to it. Myrbetriq extended-release tablets should be swallowed whole with a drink of water.

The time to reach maximum concentration (T max) is 3–4 h. The absolute bioavailability is approximately 29% at a 25 mg dose and 35% at a 50 mg dose.

Oral Tablet, Extended Release

Myrbetriq Coupons, Prices, and Savings Card The average cost for 30 Tablet(s), 50mg each, is $546.99.

Vibegron (Gemtesa) and mirabegron (Myrbetriq) demonstrated similar efficacy and safety in a comparative study of the 2 treatments in female patients with overactive bladder (OAB); however, more patients preferred vibegron, according to a study presented at the 2023 AUA Annual Meeting.